Pharmaceutical Technology, May 2, 2011 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharmaceutical Technology, May 2, 2011
Special Report
Up Close and Personal
By Angie Drakulich
Regulators and standard-setting bodies are re-examining over-the-counter drugs.
Beyond Micronization
By Erik Greb
Emerging methods could provide alternative ways of producing inhalable drug particles.
Peer-Reviewed Research
Gelatin Capsule Shell Cross-Linking
By Xiling Song , Yong Cui , Minli Xie
The authors develop a pratical approach to avoid unwanted interactions between pepsin and SLS in dissolution Tier II tests.
Pharmaceutical Excipients for Hot-Melt Extrusion
By Matthias Karl , Dejan Djuric , Karl Kolter
The authors examine the influence of glass-transition temperature, melt viscosity, degradation temperature, and process settings.
From The Editor
Perception and Reality
By Michelle Hoffman
Those who doubt there's faith in science, should check out our annual Bioprocessing Survey.
PharmTech Talk
IBM Reboots Drug Discover
By Erik Greb
Can the semiconductor industry help Big Pharma develop therapies?
Agent-in Place
Common Sense Required
By Control, a senior compliance officer
Many factors affect research results.
Report from Hungary
By Sean Milmo
Eastern Europe's pharmaceutical leader, Hungary, is working to maintain its number-one status while also pursuing new avenues, especially in biopharmaceuticals.
Global Healthcare on the Ground: Roche Takes on Illnesses in LDCs
By Christina I. Ortiz
Efforts are made to educate health workers in less developed countries.
In the Spotlight
In the Spotlight
Editor's picks of analytical instrumentation products for May 2011.
Washington Report
Experts Ponder Ways to Fill Pharma Pipeline
By Jill Wechsler
FDA, NIH and industry seek new strategies to spur drug development and promote access to therapies.
Manufacturing Strategies for Biosimilars
By Albert Lee , Dinkar Saran , Mark Mynhier
Innovator and generic-drug companies need to adapt to compete in the biosimilars market.
Packaging Forum
INTERPHEX Innovations
By Hallie Forcino
Visitors found new container options, child-resistant concepts, and serialization solutions. This article contains bonus online material.
Pharma Ingredients
The Marriage of Small Molecules and Biologics
By Patricia Van Arnum
Approaches in using small-molecule and peptide synthesis offer promise in widening the scope of drug candidates.
Formulation Development Forum: Nanosponges
By Patricia Van Arnum
Nanosponges, a controlled-release nanoparticle system, shows promise in targeted drug delivery
Inside USP
Inside USP: Monograph Makeover Requires Industry Input
By Karen Russo , Shawn Dressman
Monograph modernization and standards donation go hand in hand.
Outsourcing Outlook
Supply Chain Pain
By Jim Miller
Lessons from the earthquake in Japan show the vulnerability of the bio/pharma supply chain.
Industry Leader
Q&A with Greg Irace,sanofi-aventis
Greg Irace, president of sanofi-aventis, on recent industry trends.
India's Biotech Industry is Poised for Exponential Growth
By Alan Eisenberg
India has the potential to become the new star of the biotechnology industry.
Book Review
An Indispensible Book on Disposables
By A. Mark Trotter
Students and professionals can learn a good deal from a review of single-use technology.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here